Digital PNG artwork · delivered by email | Secure checkout · no physical shipping
Hedi Raizer

Journal 6 min read

How Is Muscle Protein Synthesis Measured?

Muscle protein synthesis is measured by tracer incorporation, biopsy-based signalling assays and transcriptomic readouts. This page covers the methods and the research models in which they have been applied.

peptides-pro Editorial

Muscle protein synthesis (MPS) is the fractional or absolute rate at which amino acids are incorporated into skeletal muscle protein. It is not a single assay but a family of readouts: direct tracer-based measurement of incorporation, indirect measurement of intracellular anabolic signalling, and transcriptomic or proteomic profiling of the muscle response. In the research literature the term is used interchangeably with 'muscle protein turnover' when breakdown is measured alongside synthesis, and with 'anabolic response' when the endpoint is a change in lean mass rather than a rate.

The pathway most commonly interrogated in this work is the mechanistic target of rapamycin (mTOR) signalling axis, which is the node through which amino acid availability, insulin and mechanical loading converge on translation initiation in skeletal muscle [6].

Research Studies

HMB and the human skeletal muscle transcriptome

Beta-hydroxy beta-methylbutyrate (HMB) is an endogenous metabolite of the essential amino acid leucine. In a study of young males (n = 14), total RNA was extracted from m. vastus lateralis biopsies taken before and approximately 2.5 h after oral consumption of about 3 g HMB, and the muscle transcriptome was examined to characterise mechanistic effects beyond the established effect on muscle protein turnover [2]. The same report describes HMB as acutely stimulating muscle protein synthesis and attenuating muscle protein breakdown in skeletal muscle [2].

HMB and protein kinase activity in an exercise model

A registered trial assessed the influence of HMB free acid supplementation at 90 mg/kg of fat-free body mass per day for 21 days on protein kinase activity and selected hormone levels, with subsequent improvements in muscle protein synthesis, lean body mass content and aerobic capacity as endpoints [7]. This design links a signalling readout (protein kinase activity) to a functional readout (lean mass, aerobic capacity) in the same protocol.

HMB and mTOR signalling in cirrhosis

In cirrhosis, loss of skeletal muscle mass is described as the most common and potentially reversible complication, increasing morbidity and mortality before, during and after liver transplantation, and no proven treatments exist for its prevention or reversal [6]. The stated hypothesis is that reduced skeletal muscle mass in cirrhosis is due to myostatin-mediated impairment of mTOR signalling, resulting in reduced protein synthesis and increased autophagy [6]. This is a disease-model application of the same pathway readout used in healthy-volunteer work.

HMB and muscle mass after orthopaedic knee surgery in female athletes

A randomised clinical trial in female athletes evaluated quadriceps and hamstring muscle size and function after anterior cruciate ligament repair or reconstruction, comparing standard of care plus calcium-beta-hydroxy-beta-methylbutyrate (caHMB) against placebo [5]. The trial design pairs a surgical recovery model with a supplement arm, and the outcomes are anatomical (muscle size) and functional rather than tracer-based.

HMB and nutritional status in lung transplant candidates

A registered trial evaluated hydroxymethylbutyrate supplementation in lung transplant candidates receiving pulmonary rehabilitation [3]. The rationale given is that optimising nutritional status during the waiting period may improve exercise capacity, support early mobilisation after transplantation, shorten hospitalisation and support survival [3]. Muscle endpoints here are embedded in a rehabilitation and transplant context rather than measured as a synthesis rate.

Whey, casein and anabolic signalling after strength training

A study compared the acute anabolic effects of native whey, whey protein concentrate 80 (WPC-80) and milk after a bout of strength training in young and elderly participants [8]. The stated hypothesis was that native whey would produce greater stimulation of muscle protein synthesis and intracellular anabolic signalling than WPC-80, and that WPC-80 would produce a stronger stimulus than milk [8]. This is a direct comparison of protein sources using both a synthesis endpoint and a signalling endpoint.

IGF-I and the doping-control measurement problem

Insulin-like growth factor I (IGF-I) is one of the most used hormones in sport and is included on the WADA list of banned molecules, alongside human chorionic gonadotropin (hCG) [1]. Male athletes may use pharmaceutical preparations of hCG to stimulate testosterone production before competition, and IGF-I to stimulate muscle protein synthesis, promote glycogen storage and improve lipolysis [1]. A technical note describes the development of a UHPLC-MS/MS method for analysis of hCG and IGF-I from dried blood spots, a microsampling strategy intended to improve compound stability, simplify sample collection and pre-analytic phases, and facilitate automation [1]. This is a measurement-methodology study, not an efficacy study.

Metformin and muscle outcomes in elderly patients with type 2 diabetes

A registered study examined whether metformin correlates positively or negatively with muscle strength, muscle mass and physical function in elderly patients with type 2 diabetes [4]. The background cites a 2019 Asian Working Group for Sarcopenia report giving sarcopenia prevalence among elderly Asians of 5.5% to 25.7%, with males at 5.1% to 21.0% and females at 4.1% to 16.3%, and a prevalence of 14.8% reported in Chinese diabetes patients [4]. Muscle mass and strength are the endpoints; synthesis rate is not the primary readout in this design.

Comparison of measurement approaches across the cited work

ApproachWhat it measuresExample from the cited work
Tracer incorporationRate of amino acid incorporation into muscle proteinNot directly reported in the cited sources
Intracellular signallingActivity of protein kinases and mTOR-axis signallingHMB free acid and protein kinase activity over 21 days [7]; myostatin-mediated impaired mTOR signalling hypothesised in cirrhosis [6]
Transcriptomic profilingMuscle RNA expression before and after an interventionM. vastus lateralis biopsies before and ~2.5 h after ~3 g HMB in young males [2]
Anatomical and functional outcomesMuscle size, strength, physical function, aerobic capacityQuadriceps and hamstring size after ACL surgery with caHMB or placebo in female athletes [5]; lean body mass and aerobic capacity with HMB free acid [7]; muscle strength and mass with metformin in elderly type 2 diabetes [4]
Analytical detection in biological matrixConcentration of a hormone or growth factor in a sampleUHPLC-MS/MS for hCG and IGF-I from dried blood spots [1]

Two limitations should be stated plainly. First, several of the records above are registered trial descriptions rather than completed reports; they describe intended endpoints and hypotheses, not observed results. Second, the transcriptomic and signalling data cited here come from human muscle biopsy studies in specific populations — young males [2], elderly patients with type 2 diabetes [4], female athletes after knee surgery [5], lung transplant candidates [3], and patients with cirrhosis [6] — and findings in one of those populations should not be assumed to hold in another. No animal-only or in vitro measurement data are supplied in the evidence block for this page.

If you are reading this for personal health reasons

The materials described here are sold for laboratory research use only, and we do not provide dosing, administration or medical guidance of any kind. Nothing on this page is a recommendation to use any compound, and no outcome is promised or implied. If you are considering a compound for yourself, speak to a licensed clinician.

Sources

WhatsApp